MedTrace Logo

Marcaine Use in Laparoscopic Gynecological Surgery

NCT01861665 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-10-12

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to compare incisional pain in patients receiving pre-incisional versus post operative Marcaine injection.

Conditions

  • Post-operative Pain

Interventions

DRUG

Marcaine- 0.25%

Marcaine 0.25% administered pre-incision.

DRUG

Marcaine 0.25%.

Marcaine 0.25% administered post-incision.

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Glenn Schattman, MD · Weill Medical College of Cornell

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01861665 on ClinicalTrials.gov